StockData
Neuphoria Therapeutics Inc. logo

Neuphoria Therapeutics Inc. (NEUP) stock

NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Sep 18, 2026Score 5/30
$2.28+0.01 (+0.44%)

Close on Nov 18, 2026Market cap $68.54KP/E –Yield –

Neuphoria Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2026 it was $1.17M, down 92.5% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$1.17M-92.5%
FY2025Jun 30, 2025$15.65M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2025CQ1 2025Mar 31, 2025$15.00M–
Q2 FY2025CQ4 2024Dec 31, 2024$662.72K–

More Neuphoria Therapeutics figures

See a number that looks wrong?